Metraipolis › archive › dc_89fb3b90d552

Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies — Europe PMC PMID:42747714

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42747714
DOI
10.1007/s11882-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-08T15:32:25.179Z
SHA-256 of the archived text
37b6ab9d3fbbc183b40a4e00a40e17508f16bab932145d6e0c31c309a849bc24
Stable URL of this page
https://metraipolis.com/documento/dc_89fb3b90d552

How to cite

Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies — Europe PMC PMID:42747714 — Europe PMC (en), https://europepmc.org/article/MED/42747714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_89fb3b90d552 (Metraipolis archive dc_89fb3b90d552, sha256 37b6ab9d3fbbc183b40a4e00a40e17508f16bab932145d6e0c31c309a849bc24)
BibTeX
@misc{dc89fb3b90d552,
  title = {Type 2-low Asthma: Epidemiology, Multiomics, and Emerging Therapies — Europe PMC PMID:42747714},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42747714},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_89fb3b90d552; sha256 37b6ab9d3fbbc183b40a4e00a40e17508f16bab932145d6e0c31c309a849bc24},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42747714. Agents can read the archived copy with the MCP tool read_document.